Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
0.88
-0.01 (-1.07%)
At close: Oct 03, 2025, 3:59 PM
0.87
-0.77%
After-hours: Oct 03, 2025, 07:54 PM EDT
-1.07% (1D)
| Bid | 0.83 |
| Market Cap | 17.22M |
| Revenue (ttm) | 615.92K |
| Net Income (ttm) | -11.39M |
| EPS (ttm) | -0.68 |
| PE Ratio (ttm) | -1.29 |
| Forward PE | -1.89 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.91 |
| Volume | 572,025 |
| Avg. Volume (20D) | 533,319 |
| Open | 0.90 |
| Previous Close | 0.89 |
| Day's Range | 0.85 - 0.91 |
| 52-Week Range | 0.78 - 3.38 |
| Beta | 0.80 |
| Ex-Dividend Date | n/a |
About LEXX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LEXX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LEXX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLexaria Bioscience Corp. is scheduled to release its earnings on
Nov 25, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-31.37%
Lexaria Bioscience shares are trading lower after ...
Unlock content with
Pro Subscription
5 months ago
-20.12%
Lexaria Bioscience shares are trading lower. The company announced a $2 million registered direct offering.
2 months ago · accessnewswire.com
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 StudyDehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus® DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus® DehydraTECH-GLP-1...
2 months ago · thenewswire.com
Lexaria Provides Positive Interim Results on Partial 8-week Data From Phase 1b, GLP-1-H24-4 StudyDehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus
